Skip to Main Content

Author Details

Emily Hua
Center for Cancer Research
2004
12
12
PMIDPaper TitleJournal TitlePublished Year
30006619Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases.Nat Commun2018
30006619Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases.Nat Commun2018
27245829Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.Clin Cancer Res2016
27245829Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.Clin Cancer Res2016
26319493Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis.Clin Exp Metastasis2015
26319493Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis.Clin Exp Metastasis2015
24634373Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Clin Cancer Res2014
24634373Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Clin Cancer Res2014
22011930Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.Pharm Res2012
22011930Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.Pharm Res2012
21953073Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.Clin Exp Metastasis2011
21953073Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.Clin Exp Metastasis2011
19723875Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.Mol Cancer Res2009
19723875Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.Mol Cancer Res2009
19789319Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.Clin Cancer Res2009
19789319Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.Clin Cancer Res2009
18649117Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization.Clin Exp Metastasis2008
18649117Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization.Clin Exp Metastasis2008
18089805Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.Cancer Res2007
18089805Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.Cancer Res2007
15713901Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cells.Mol Cancer Ther2005
15713901Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cells.Mol Cancer Ther2005
15623615Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells.Clin Cancer Res2004
15623615Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells.Clin Cancer Res2004
  • 1 - 24 of 24

Recommended Authors

Northwestern University, Feinberg School of Medicine
Career Start Year 2013
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 0
Northwestern University
Career Start Year 2005
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 1
Medical University of Vienna
Career Start Year 2003
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 4
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Oncology R&D
Career Start Year 2001
Number of shared co-authors 0
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 0
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 2
St. Jude Children's Research Hospital
Career Start Year 1997
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 1
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 0
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 1
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 1
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Career Start Year 1995
Number of shared co-authors 0
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Career Start Year 1993
Number of shared co-authors 7
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 6
Ontario Brain Institute
Career Start Year 1990
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 1
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 0
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 2
Moffit Cancer Center
Career Start Year 1986
Number of shared co-authors 2
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 2
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 1
University of Oxford
Career Start Year 1981
Number of shared co-authors 0
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 10
Center for Cancer Research
Co-authored papers 8
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Center for Cancer Research
Co-authored papers 4
Co-authored papers 4
National Cancer Institute
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Co-authored papers 3
Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University
Co-authored papers 3
Schleswig-Holstein University Medical Center
Co-authored papers 3
Drug Metabolism and Pharmacokinetics
Co-authored papers 2
School of Pharmacy, Texas Tech University Health Sciences Center
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Pfizer Inc.
Co-authored papers 2
RNA Therapeutics Institute, University of Massachusetts Chan Medical School
Co-authored papers 2
Co-authored papers 2
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Co-authored papers 2
School of Pharmacy, Texas Tech University Health Sciences Center
Co-authored papers 2
Program Resources Inc. NCI-FCDRC
Co-authored papers 2
Center for Cancer Training, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Rhode Island Hospital
Co-authored papers 2
Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research
Co-authored papers 1
From Foundation Medicine
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
University of Kansas School of Medicine
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1